How should we talk about our emotions?
Kimberley asks her guest, clinical psychologist Dr Emma Hepburn, how we can manage and regulate our emotions.
another news portal
Kimberley asks her guest, clinical psychologist Dr Emma Hepburn, how we can manage and regulate our emotions.
Zambia accuses the U.S. of linking a $2 billion health assistance deal to access to its rich mineral resources
For patients with Crohn’s disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy is showing results that offer hope for
A new study led by researchers from VIB and KU Leuven shows that Parkinson’s disease can be divided into distinct subtypes, helping explain why a
In a Perspective published today in the inaugural issue of Brain Health (https://doi.org/10.61373/bh026p.0006), an international team of investigators argues that the human microplastic burden has
When the COVID-19 pandemic shut down clinics and forced face-to-face interactions behind masks, autism diagnoses for many children came to a halt.
The International Progressive MS Alliance announces the MS Clinical and Imaging Data Resource (MS CIDR) is now accepting applications for data access.
A cruise ship with nearly 150 people is waiting for help off Cape Verde’s coast in the Atlantic Ocean after three passengers died and three
A Closer Look at a Viral Claim The post Can Ivermectin and Mebendazole Treat Cancer? first appeared on Science-Based Medicine.
It turns out that Tweeting about RCTs 100+ times is a lot easier than delivering even a single RCT. The post Dr. Vinay Prasad Said
Alison Scott-Wright, also known as ‘The Magic Sleep Fairy’ has appeared on TV giving advice around improving the sleep of babies.
A researcher from the University of Kansas has led a large-scale study of university undergraduates to better understand how psychological conditions such as depression, anxiety
Climate change is likely to drive rodent-borne arenaviruses into parts of South America that have never faced these diseases, putting new communities of people at
Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the